04/09/2024 3:30 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 3:42 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:29 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:33 PM | Cohen Darrel P. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:36 PM | Rothera Mark (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:04 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 7:40 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Subject) Viracta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/27/2024 6:56 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | ROYSTON IVOR (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:54 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:04 PM | FORWARD VENTURES V LP (Filed by) Viracta Therapeutics, Inc. (Subject) Viracta Therapeutics (Subject)
| Form SC 13G | |
11/28/2023 6:01 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 6:03 PM | ROYSTON IVOR (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 6:06 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:30 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:30 AM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 6:01 AM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 5:49 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 5:52 PM | ROYSTON IVOR (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 5:47 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 3:46 PM | Cohen Darrel P. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 3:51 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 4:58 PM | Cohen Darrel P. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2023 7:02 AM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 6:36 AM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 5:34 PM | ROYSTON IVOR (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:41 PM | Rubino Stephen (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:49 PM | Simon Barry J. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:11 PM | Barlow Jane F (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:13 PM | Borellini Flavia (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:19 PM | Chung Jane (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:22 PM | DARCY THOMAS E (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:26 PM | Murphy Samuel Lafayette (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:28 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 6:29 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 6:30 PM | Pomerantz Roger (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 6:32 PM | ROYSTON IVOR (Reporting) Viracta Therapeutics, Inc. (Issuer) Viracta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:01 PM | Chevallard Daniel R. (Reporting) Viracta Therapeutics, Inc. (Subject) Viracta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023 3:23 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2023 3:52 PM | Viracta Therapeutics, Inc. (Filer) Viracta Therapeutics (Filer)
| Form 8-K/A | |